Efgartigimod + Telitacicept (1-week interval) group
KY2024-298
Unknown small_molecule active
Quick answer
Efgartigimod + Telitacicept (1-week interval) group for Myasthenia Gravis is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Myasthenia Gravis
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active